Effects of a bisphosphonate (1-hydroxy ethylidene-1,1 bisphosphonic acid) on osteoclast number during prolonged bed rest in healthy humans.
Acute osteoporosis is known to occur after immobilization in spinal cord injured patients and is related to an early increase in osteoclastic bone resorption. Whether osteoporosis develops in healthy immobilized human patients is still a matter of controversy. Furthermore, acute osteoporosis was thought to be a good model to study the effects of weightlessness on the human skeleton and to adapt preventive procedures. A bed rest experiment was developed in the USSR on 15 healthy human volunteers to determine the precise effects on bone structure and cell activities. A preventive protocol, including an anti-osteoclastic drug (1-hydroxyethylidene-1,1 bisphosphonic acid; K salt) was investigated. Two transiliac bone biopsies were performed on the 15 individuals before and at the end of the 120-day bed rest period. Undecalcified bone biopsies were studied with automatic and semi-automatic image analyzers specially devoted to bone histomorphometry. Trabecular bone volume, osteoid amount, and eroded surfaces were measured. Osteoclast number was measured after histochemical identification of tartrate-resistant acid phosphatase. After the bed rest period, an insignificant bone loss was observed in healthy humans while osteoclast number was highly increased. In bisphosphonate-treated subjects, osteoclast number was markedly reduced and so was osteoid amount. Bisphosphonates were shown to present a highly cytotoxic activity on osteoclasts, a finding that has never been demonstrated in normal subjects.
Chappard
D
D
Laboratoire de Biologie du Tissu Osseux, Faculté de Médecine, Saint Etienne, France.
Alexandre
C
C
Palle
S
S
Vico
L
L
Morukov
B V
BV
Rodionova
S S
SS
Minaire
P
P
Riffat
G
G
D000328:Adult; D001862:Bone Resorption / Q000187:drug effects; D002452:Cell Count; D012968:Etidronic Acid / Q000627:therapeutic use*; D006801:Humans; D007103:Immobilization; D008297:Male; D010010:Osteoclasts / Q000187:drug effects / Q000473:pathology*; D010024:Osteoporosis / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D012016:Reference Values
D012968:Etidronic Acid